Catalyst
Slingshot members are tracking this event:
BioPharmX Corporation (BPMX) set to release phase 2b study data on BPX-01, a drug treating acne vulgaris, in April or May of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BPMX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 03, 2017
Occurred Source:
http://biopharmx.investorroom.com/2017-05-03-BioPharmX-Reports-Positive-Topline-Results-of-BPX-01-Topical-Minocycline-for-Acne
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Bpx-01, Acne Vulgaris, Phase 2b Results
